Recently, it was also reported that pathologic TGFβ release in association with bone lesions mediates the occurrence of muscle weakness by causing alterations of Ca2+-dependent muscle force production in a metastatic breast cancer model [32]. This evidence concerns the gene TGFB1 and breast carcinoma.